Eli Lilly & Co. (LLY) Tops Q1 EPS by 9c; Reaffirms FY13 Outlook
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,152.93 +0.04%
Revenue Growth %: +25.9%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +25.9%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.66 billion.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly (LLY) PT Raised to $1,284 at Guggenheim
- Investing.com’s stocks of the week
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
